Zeltiq Aesthetics Names Mark Foley President,CEO

Colorescience Names Mary Fisher As CEO - Quick Facts

ZELTIQ Aesthetics Q4 12 Earnings Conference Call At 5:00 PM ET

Trade ZLTQ now with

8/24/2012 9:46 AM ET

Zeltiq aesthetics, Inc.(ZLTQ: Quote), a medical technology company, Friday said that it appointed Mark Foley as President and Chief Executive Officer with immediate effect. Mark has been serving as interim president and CEO since April and a member of the Board of Directors since 2009.

Foley has 25 years of experience in the medical device industry and served in senior operating roles with large cap companies and venture-backed start-ups.

Thursday, ZELTIQ closed at $5.04 on the Nasdaq.

Click here to receive FREE breaking news email alerts for ZELTIQ Aesthetics, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

<<Previous 74 Articles

Editors Pick

Stocks Come Under Pressure Amid Worries About Fed - U.S. Commentary

After moving mostly higher over the course of morning trading on Wednesday, stocks have shown a notable move back to the downside in the afternoon. The major averages have pulled back well off their highs for the session and into negative territory. The major averages have moved roughly sideways in recent trading, lingering near their new lows for the session.

Immigration Reform Bill Clears Senate Judiciary Committee

Comprehensive immigration reform legislation took a step toward approval on Tuesday, as the members of the Senate Judiciary Committee voted to send the bill to the Senate floor. The Senate Judiciary Committee voted 13 to 5 in favor of the bill, with three Republicans joining with the panel's ten Democrats in voting to support the legislation.

U.S. Existing Home Sales Edge Up To Three-Year High In April

Existing home sales in the U.S. saw a modest increase in the month of April, according to a report released by the National Association of Realtors on Wednesday. NAR said existing home sales climbed 0.6 percent to a seasonally adjusted annual rate of 4.97 million in April from an upwardly revised 4.94 million in March.